Curio Wealth LLC acquired a new position in shares of Aflac Incorporated (NYSE:AFL – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 350 shares of the financial services provider’s stock, valued at approximately $36,000.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Parallel Advisors LLC raised its holdings in Aflac by 8.5% during the fourth quarter. Parallel Advisors LLC now owns 9,208 shares of the financial services provider’s stock valued at $953,000 after buying an additional 719 shares in the last quarter. SlateStone Wealth LLC raised its holdings in Aflac by 2.3% during the fourth quarter. SlateStone Wealth LLC now owns 17,735 shares of the financial services provider’s stock valued at $1,835,000 after buying an additional 400 shares in the last quarter. GWN Securities Inc. bought a new position in Aflac during the fourth quarter valued at about $878,000. Glenview Trust co raised its holdings in Aflac by 1.0% during the fourth quarter. Glenview Trust co now owns 18,643 shares of the financial services provider’s stock valued at $1,928,000 after buying an additional 186 shares in the last quarter. Finally, Patten & Patten Inc. TN raised its holdings in Aflac by 4.2% during the fourth quarter. Patten & Patten Inc. TN now owns 4,541 shares of the financial services provider’s stock valued at $470,000 after buying an additional 183 shares in the last quarter. 67.44% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analyst Weigh In
Several equities analysts have weighed in on AFL shares. Piper Sandler cut their target price on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a report on Friday, February 7th. BMO Capital Markets initiated coverage on Aflac in a research note on Thursday, January 23rd. They issued a “market perform” rating and a $111.00 price objective on the stock. Keefe, Bruyette & Woods dropped their price objective on Aflac from $107.00 to $104.00 and set a “market perform” rating on the stock in a research note on Wednesday, February 12th. StockNews.com upgraded Aflac from a “sell” rating to a “hold” rating in a research note on Friday, February 14th. Finally, Evercore ISI dropped their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating on the stock in a research note on Wednesday, December 4th. Two research analysts have rated the stock with a sell rating, eleven have given a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $103.36.
Aflac Stock Up 1.1 %
AFL stock opened at $108.47 on Tuesday. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The business’s 50-day simple moving average is $105.51 and its 200 day simple moving average is $107.67. The company has a market cap of $59.29 billion, a PE ratio of 11.30, a price-to-earnings-growth ratio of 3.24 and a beta of 0.93. Aflac Incorporated has a twelve month low of $79.31 and a twelve month high of $115.50.
Aflac (NYSE:AFL – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. On average, research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.
Insider Buying and Selling at Aflac
In other Aflac news, Director Charles D. Lake II sold 29,802 shares of Aflac stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $107.29, for a total transaction of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares of the company’s stock, valued at approximately $5,360,422.98. The trade was a 37.36 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Audrey B. Tillman sold 24,744 shares of Aflac stock in a transaction that occurred on Friday, December 27th. The shares were sold at an average price of $103.40, for a total value of $2,558,529.60. Following the sale, the executive vice president now directly owns 222,618 shares in the company, valued at $23,018,701.20. The trade was a 10.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 55,546 shares of company stock valued at $5,863,616. 0.90% of the stock is currently owned by corporate insiders.
Aflac Company Profile
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.
See Also
- Five stocks we like better than Aflac
- Earnings Per Share Calculator: How to Calculate EPS
- Can TikTok Stock Picks Really Make You Rich?
- How to trade penny stocks: A step-by-step guide
- The “Quality” Rotation: Back to Basics Investing
- 3 Small Caps With Big Return Potential
- Occidental Petroleum: 4 Reasons to Love These Prices
Want to see what other hedge funds are holding AFL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aflac Incorporated (NYSE:AFL – Free Report).
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.